M3-Brigade Acquisition V Corp. is a Delaware-incorporated special purpose acquisition company (SPAC) that completed its initial public offering in late 2021. The company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization or other similar business combination with one or more businesses. M3-Brigade Acquisition V does not currently conduct any operations other than identifying and evaluating prospective target businesses.
The SPAC is jointly sponsored by affiliates of M3, Inc., a Tokyo-based provider of healthcare information, technology and services, and Brigade Capital Management, a U.S. alternative investment manager. Through these strategic partnerships, M3-Brigade Acquisition V seeks to leverage industry expertise in healthcare, technology and financial structuring. The company’s investment focus encompasses growth-oriented enterprises, particularly those operating within or adjacent to digital health, medical information services and related technology platforms.
As a blank check vehicle, M3-Brigade Acquisition V is governed by a board of directors and management team with experience in deal sourcing, capital markets and regulatory compliance. The SPAC has a defined timeframe to complete a qualifying business combination, after which any remaining funds will be returned to public shareholders if no transaction is consummated. M3-Brigade Acquisition V’s leadership emphasizes disciplined due diligence and strategic partnerships to identify value-creating opportunities for investors.
AI Generated. May Contain Errors.
